Literature DB >> 18752119

Characteristic sequence motifs located at the genomic breakpoints of the translocation t(12;16) and t(12;22) in myxoid liposarcoma.

Hua Xiang1, Jian Wang, Masanori Hisaoka, Xiongzeng Zhu.   

Abstract

AIMS: To analyse the characteristic sequence motifs around genomic breakpoints of translocations, t(12;16) and t(12;22), and to study the mechanisms underlying these chromosomal translocations in myxoid liposarcomas (MLS).
METHODS: Genomic DNA sequences derived from t(12;16) and t(12;22) were amplified by long-distance polymerase chain reaction (PCR) in six cases of MLS, and the DNA sequences around the breakpoints were analysed.
RESULTS: Genomic sequences of the FUS-CHOP or EWS-CHOP fusion gene were amplified in five and one MLS, respectively. Our sequence analysis revealed that the gene fusions were generated between intron 1 of the CHOP and either intron 5 (type II) or 7 (type I), or 8 (type III) of the FUS, or intron 7 of the EWS. The breakpoints in intron 1 of the CHOP were located near or within Alu repetitive sequences in the six cases. Sequences homologous to consensus recognition motifs of Translin were present adjacent to the breakpoints in the FUS, EWS, and CHOP genes. Sequences homologous to the topoisomerase II consensus site and palindromic oligomer sequences were also frequently found around the breakpoints in these genes. Moreover, Chi or Chi-like sequences were found in three cases, alternating purine-pyrimidine tracts and polyadenine/polythymine sequences were each found in one case.
CONCLUSIONS: Our results suggest that characteristic sequence motifs located at the FUS, EWS and CHOP breakpoint regions, including Alu and palindromic oligomer sequences, are involved in the mechanisms creating chromosomal translocations in MLS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18752119     DOI: 10.1080/00313020802320424

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  5 in total

Review 1.  The TET family of proteins: functions and roles in disease.

Authors:  Adelene Y Tan; James L Manley
Journal:  J Mol Cell Biol       Date:  2009-09-24       Impact factor: 6.216

2.  Phase II study of amrubicin (SM-5887), a synthetic 9-aminoanthracycline, as first line treatment in patients with metastatic or unresectable soft tissue sarcoma: durable response in myxoid liposarcoma with TLS-CHOP translocation.

Authors:  Sumati Gupta; Launce Gouw; Jennifer Wright; Sant Chawla; Debbie Pitt; Mark Wade; Ken Boucher; Sunil Sharma
Journal:  Invest New Drugs       Date:  2016-02-20       Impact factor: 3.850

3.  Translocation and deletion breakpoints in cancer genomes are associated with potential non-B DNA-forming sequences.

Authors:  Albino Bacolla; John A Tainer; Karen M Vasquez; David N Cooper
Journal:  Nucleic Acids Res       Date:  2016-04-15       Impact factor: 16.971

4.  Targeted next-generation sequencing of circulating free DNA enables non-invasive tumor detection in myxoid liposarcomas.

Authors:  A E Eisenhardt; A Schmid; S U Eisenhardt; David Braig; J Esser; Z Brugger; U Lausch; J Kiefer; M Braig; A Runkel; J Wehrle; R Claus; P Bronsert; A Leithner; B Liegl-Atzwanger; J Zeller; R Papini; M von Laffert; B M Pfitzner; G Koulaxouzidis; R E Giunta
Journal:  Mol Cancer       Date:  2022-02-14       Impact factor: 27.401

5.  Involvement of a citrus meiotic recombination TTC-repeat motif in the formation of gross deletions generated by ionizing radiation and MULE activation.

Authors:  Javier Terol; Victoria Ibañez; José Carbonell; Roberto Alonso; Leandro H Estornell; Concetta Licciardello; Ivo G Gut; Joaquín Dopazo; Manuel Talon
Journal:  BMC Genomics       Date:  2015-02-13       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.